Catalyst Pharmaceutical Partners (CPRX)

[gaileo6]

I really do not think it will pull back that much if at all. The float is only about 30mil and about 4mil of that is owned by institutions. That leaves about 26mil for us to play with. About 6mil of that is being shorted. So if we buy and hold then the shorts have choice but to cover their position. Win for those holding. Institutions for the most part do not churn their stock positions. CPRX has a winner in Firdapse. It has already been used in Europe for years without any problems. It is for the treatment of LEMS, a life threatening disease, for which there is no other treatment. They have a very very high probability of it being approved for use here in the USA, and pretty quickly. Someone that is really good figuring out the numbers should try to apply what an approval will do for CPRX. In 2012 it generated over 12 million in sales in Europe for BioMarin from whom CPRX got the rights to market it in the USA. I would think it would generate at least those numbers in the US. This is not the only iron CPRX has in the fire. Look into it my friends and have a nice day. Good Luck